Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-L1-related Disease”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Not applicableUnknownNCT05426317
What this trial is testing

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Who this might be right for
MelanomaNon Small Cell Lung CancerRenal Cancer
University Hospital, Clermont-Ferrand 100
Testing effectiveness (Phase 2)Study completedNCT05882734
What this trial is testing

Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

Who this might be right for
Non-Small Cell Lung Cancer
EMD Serono Research & Development Institute, Inc. 61
Not applicableUnknownNCT05288569
What this trial is testing

IrAE Prediction of Anti-PD-1/L1 in Lung Cancer

Who this might be right for
Immune Checkpoint InhibitorsLung Cancer
Peking Union Medical College Hospital 120
Not applicableUnknownNCT05819905
What this trial is testing

Radiomics for prEdiction of lunG cAncer biologY

Who this might be right for
Non Small Cell Lung CancerPET/CTPD-L1+1 more
Poitiers University Hospital 600
Early research (Phase 1)Active Not RecruitingNCT05787587
What this trial is testing

PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsBreast CancerOvarian Cancer+6 more
IDEAYA Biosciences 216
Not applicableNot Yet RecruitingNCT07331701
What this trial is testing

Association of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study

Who this might be right for
Lung NeoplasmsTumor Immune Microenvironment
Seoul National University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03082534
What this trial is testing

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Who this might be right for
HNSCCLip SCCOral Cavity Cancer+9 more
University of California, San Diego 78
Not applicableLooking for participantsNCT07618936
What this trial is testing

Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients

Who this might be right for
PD-L1 Gene MutationPD-L1 Gene AmplificationPD-L1-related Disease+1 more
Tianjin Medical University 500
Not applicableStudy completedNCT03125603
What this trial is testing

Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungDrug-Related Side Effects and Adverse Reactions
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 80
Not applicableActive Not RecruitingNCT06876402
What this trial is testing

Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Hellenic Cooperative Oncology Group 367
Not applicableUnknownNCT03917537
What this trial is testing

WGA in Platinum-refractory HNSCC Underwent Nivolumab

Who this might be right for
HNSCC
Chang Gung Memorial Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT06254911
What this trial is testing

Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma

Who this might be right for
Oropharynx Cancer, Stage I
Emory University 20
Not applicableUnknownNCT05995808
What this trial is testing

Cyclin D1 as a Prognostic Factor in Multiple Myeloma and Its Association With the Immunological Prognostic Factor PDL1 and Clinical and Biochemical Lab Tests

Who this might be right for
Multiple Myeloma
Sohag University 30
Testing effectiveness (Phase 2)Ended earlyNCT03451773
What this trial is testing

M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas

Who this might be right for
Cancer of PancreasPancreas CancerPancreatic Adenocarcinoma+2 more
National Cancer Institute (NCI) 7
Not applicableLooking for participantsNCT07485114
What this trial is testing

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Non Small Cell Lung CancerHepatocellular Carcinoma+1 more
Daniel Keizman 300
Testing effectiveness (Phase 2)Study completedNCT05535569
What this trial is testing

Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Cancer

Who this might be right for
Recurrent/Metastatic Gastric Cancer
Yonsei University 50
Not applicableStudy completedNCT05387512
What this trial is testing

Real-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Affiliated Hospital of Nantong University 60
Post-approval studies (Phase 4)Temporarily pausedNCT04036721
What this trial is testing

Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis

Who this might be right for
Lung Neoplasm MalignantInterstitial Lung Disease
National Institute for Tuberculosis and Lung Diseases, Poland 85
Not applicableLooking for participantsNCT07249060
What this trial is testing

Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients

Who this might be right for
Immune-Related Adverse EventsLupus Erythematosus, SystemicSjogren Syndrome+3 more
Hospital Universitario Araba 300
Early research (Phase 1)Ended earlyNCT04958434
What this trial is testing

Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic CancersMetastatic Human Papillomavirus-Related Malignant Neoplasm
Transcenta Therapeutics (Hangzhou) Co., Ltd. 19
Next Page